Literature DB >> 12595473

Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production.

Mairi C Noverr1, Gary M Cox, John R Perfect, Gary B Huffnagle.   

Abstract

Cryptococcal phospholipase (PLB1) is a secreted enzyme with lysophospholipase hydrolase and lysophospholipase transacylase activities. To investigate the role of PLB1 in the evasion of host immune responses, we characterized pulmonary immune responses to the parental (H99), the plb1 mutant, and the plb1(rec) reconstituted mutant strains of Cryptococcus neoformans in mice. PLB1 was required for virulence during infection acquired via the respiratory tract. Mice infected with either H99 or the plb1(rec) strain generated a nonprotective inflammatory response with subsequent eosinophilia, while mice infected with the plb1 mutant generated a protective immune response that controlled the infection. Because PLB1 is believed to facilitate virulence through host cell lysis, we examined the interaction of these strains with macrophages. The plb1(rec) mutant exhibited decreased survival during coculture with macrophages. One factor which may be involved in the survival of yeast in the presence of macrophages is fungal eicosanoid production. Host eicosanoids have been shown to down-modulate macrophage functions. plb1 exhibited a defect in eicosanoid production derived from exogenous arachidonoyl-phosphatidylcholine, suggesting that PLB1 is required for the release of arachidonic acid from phospholipids. These data suggest that cryptococcal PLB1 may act as a virulence factor by enhancing the ability to survive macrophage antifungal defenses, possibly by facilitating fungal eicosanoid production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595473      PMCID: PMC148814          DOI: 10.1128/IAI.71.3.1538-1547.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Regulation of human alveolar macrophage- and blood monocyte-derived interleukin-8 by prostaglandin E2 and dexamethasone.

Authors:  T J Standiford; S L Kunkel; M W Rolfe; H L Evanoff; R M Allen; R M Strieter
Journal:  Am J Respir Cell Mol Biol       Date:  1992-01       Impact factor: 6.914

2.  MH-S, a murine alveolar macrophage cell line: morphological, cytochemical, and functional characteristics.

Authors:  I N Mbawuike; H B Herscowitz
Journal:  J Leukoc Biol       Date:  1989-08       Impact factor: 4.962

3.  Phenotypic and functional heterogeneity of the murine alveolar macrophage-derived cell line MH-S.

Authors:  K Sankaran; H B Herscowitz
Journal:  J Leukoc Biol       Date:  1995-04       Impact factor: 4.962

4.  Suppression of murine IgM, IgG, IgA and IgE antibody responses by alveolar macrophages.

Authors:  M G Steele; H B Herscowitz
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

5.  Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines.

Authors:  M Betz; B S Fox
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

6.  Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes.

Authors:  F G Snijdewint; P Kaliński; E A Wierenga; J D Bos; M L Kapsenberg
Journal:  J Immunol       Date:  1993-06-15       Impact factor: 5.422

7.  Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression.

Authors:  S L Kunkel; M Spengler; M A May; R Spengler; J Larrick; D Remick
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

8.  Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro.

Authors:  G H Chen; J L Curtis; C H Mody; P J Christensen; L R Armstrong; G B Toews
Journal:  J Immunol       Date:  1994-01-15       Impact factor: 5.422

Review 9.  Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease.

Authors:  B J Rollins
Journal:  Mol Med Today       Date:  1996-05

10.  Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.

Authors:  G Strassmann; V Patil-Koota; F Finkelman; M Fong; T Kambayashi
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  54 in total

1.  In vitro antifungal activities of inhibitors of phospholipases from the fungal pathogen Cryptococcus neoformans.

Authors:  Ranjini Ganendren; Fred Widmer; Vatsala Singhal; Christabel Wilson; Tania Sorrell; Lesley Wright
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

2.  Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13.

Authors:  Mairi C Noverr; Nicole R Falkowski; Rod A McDonald; Andrew N McKenzie; Gary B Huffnagle
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis.

Authors:  Fred Widmer; Lesley C Wright; Daniel Obando; Rosemary Handke; Ranjini Ganendren; David H Ellis; Tania C Sorrell
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 4.  Biosynthesis and immunogenicity of glucosylceramide in Cryptococcus neoformans and other human pathogens.

Authors:  Ryan Rhome; Travis McQuiston; Talar Kechichian; Alicja Bielawska; Mirko Hennig; Monica Drago; Giulia Morace; Chiara Luberto; Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2007-08-10

5.  Coevolution of TH1, TH2, and TH17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia.

Authors:  Benjamin J Murdock; Andrew B Shreiner; Roderick A McDonald; John J Osterholzer; Eric S White; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

Review 6.  Caenorhabditis elegans as a model animal for investigating fungal pathogenesis.

Authors:  Moses Madende; Jacobus Albertyn; Olihile Sebolai; Carolina H Pohl
Journal:  Med Microbiol Immunol       Date:  2019-09-25       Impact factor: 3.402

7.  New insights on the pathogenesis of invasive Cryptococcus neoformans infection.

Authors:  Helene C Eisenman; Arturo Casadevall; Erin E McClelland
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

8.  Cysteinyl leukotrienes as novel host factors facilitating Cryptococcus neoformans penetration into the brain.

Authors:  Longkun Zhu; Ravi Maruvada; Adam Sapirstein; Marc Peters-Golden; Kwang Sik Kim
Journal:  Cell Microbiol       Date:  2016-09-25       Impact factor: 3.715

9.  Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination.

Authors:  Xiumiao He; Daniel M Lyons; Dena L Toffaletti; Fuyuan Wang; Yafeng Qiu; Michael J Davis; Daniel L Meister; Jeremy K Dayrit; Anthony Lee; John J Osterholzer; John R Perfect; Michal A Olszewski
Journal:  Am J Pathol       Date:  2012-07-28       Impact factor: 4.307

10.  Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection.

Authors:  Sarah E Hardison; Sailatha Ravi; Karen L Wozniak; Mattie L Young; Michal A Olszewski; Floyd L Wormley
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.